[Isolation obligation and therapy in tuberculosis].
Sybrecht
G W
GW
Medizinische Klinik und Poliklinik der Universität, Homburg.
D000995:Antitubercular Agents / Q000627:therapeutic use*; D001992:Bronchoalveolar Lavage Fluid; D005260:Female; D006801:Humans; D007538:Isoniazid / Q000627:therapeutic use; D009169:Mycobacterium tuberculosis / Q000187:drug effects / Q000302:isolation & purification; D010356:Patient Isolation; D011718:Pyrazinamide / Q000627:therapeutic use; D012293:Rifampin / Q000627:therapeutic use; D014397:Tuberculosis, Pulmonary / Q000175:diagnosis* / Q000188:drug therapy*
D000995:Antitubercular Agents; D011718:Pyrazinamide; D007538:Isoniazid; D012293:Rifampin